NM_014363.6(SACS):c.9508C>T (p.Arg3170Ter) AND Spastic paraplegia

Clinical significance:Pathogenic (Last evaluated: Aug 23, 2020)

Review status:1 star out of maximum of 4 stars

criteria provided, single submitter

Based on:
1 submission [Details]
Record status:

Allele description [Variation Report for NM_014363.6(SACS):c.9508C>T (p.Arg3170Ter)]

NM_014363.6(SACS):c.9508C>T (p.Arg3170Ter)

SACS:sacsin molecular chaperone [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Genomic location:
Preferred name:
NM_014363.6(SACS):c.9508C>T (p.Arg3170Ter)
  • NC_000013.11:g.23334368G>A
  • NG_012342.1:g.104335C>T
  • NM_001278055.2:c.9067C>T
  • NM_014363.6:c.9508C>TMANE SELECT
  • NP_001264984.1:p.Arg3023Ter
  • NP_055178.3:p.Arg3170Ter
  • NC_000013.10:g.23908507G>A
  • NM_014363.4:c.9508C>T
  • NM_014363.5:c.9508C>T
Protein change:
dbSNP: rs202199411
NCBI 1000 Genomes Browser:
Molecular consequence:
  • NM_001278055.2:c.9067C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_014363.6:c.9508C>T - nonsense - [Sequence Ontology: SO:0001587]


Spastic paraplegia
Spastic paraplegia, lower limb
MedGen: C0037772; Human Phenotype Ontology: HP:0001258

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
SCV001395319Invitaecriteria provided, single submitter
(Aug 23, 2020)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing



Diversity of ARSACS mutations in French-Canadians.

Thiffault I, Dicaire MJ, Tetreault M, Huang KN, Demers-Lamarche J, Bernard G, Duquette A, Larivière R, Gehring K, Montpetit A, McPherson PS, Richter A, Montermini L, Mercier J, Mitchell GA, Dupré N, Prévost C, Bouchard JP, Mathieu J, Brais B.

Can J Neurol Sci. 2013 Jan;40(1):61-6.

PubMed [citation]

Novel mutations in the sacsin gene in ataxia patients from Maritime Canada.

Guernsey DL, Dubé MP, Jiang H, Asselin G, Blowers S, Evans S, Ferguson M, Macgillivray C, Matsuoka M, Nightingale M, Rideout A, Delatycki M, Orr A, Ludman M, Dooley J, Riddell C, Samuels ME.

J Neurol Sci. 2010 Jan 15;288(1-2):79-87. doi: 10.1016/j.jns.2009.09.034. Epub 2009 Nov 4.

PubMed [citation]
See all PubMed Citations (4)

Details of each submission

From Invitae, SCV001395319.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)


This sequence change results in a premature translational stop signal in the SACS gene (p.Arg3170*). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 1,410 amino acids of the SACS protein. This variant is present in population databases (rs202199411, ExAC 0.002%). This variant has been observed in an individual affected with autosomal recessive spastic ataxia of Charlevoix-Saguenay (PMID: 23250129). ClinVar contains an entry for this variant (Variation ID: 280094). This variant disrupts the C-terminus of the SACS protein. Other variant(s) that disrupt this region (p.Arg3903*) have been determined to be pathogenic (PMID: 19892370, 21745802). This suggests that variants that disrupt this region of the protein are likely to be causative of disease. For these reasons, this variant has been classified as Pathogenic.

OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 8, 2021

Support Center